Cargando…
HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders
A high metabolic rate in myeloproliferative disorders is a common complication of neoplasms, but the underlying mechanisms are incompletely understood. Using three different mouse models of myeloproliferative disorders, including mice with defective cholesterol efflux pathways and two models based o...
Autores principales: | Gautier, Emmanuel L., Westerterp, Marit, Bhagwat, Neha, Cremers, Serge, Shih, Alan, Abdel-Wahab, Omar, Lütjohann, Dieter, Randolph, Gwendalyn J., Levine, Ross L., Tall, Alan R., Yvan-Charvet, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570097/ https://www.ncbi.nlm.nih.gov/pubmed/23319699 http://dx.doi.org/10.1084/jem.20121357 |
Ejemplares similares
-
ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms
por: Viaud, Manon, et al.
Publicado: (2020) -
Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021) -
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
por: Murphy, Andrew J., et al.
Publicado: (2013) -
Congenital hypermetabolism and uncoupled oxidative phosphorylation
por: Ganetzky, Rebecca D., et al.
Publicado: (2022) -
What is “Hyper” in the ALS Hypermetabolism?
por: Ferri, Alberto, et al.
Publicado: (2017)